US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wag! Group Co

0.1281

+0.00816.75%

Volume:1.01M

Turnover:133.87K

Market Cap:6.50M

PE:-0.33

High:0.1630

Open:0.1260

Low:0.1068

Close:0.1200

Loading ...

Overview Company News Filings

Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease

Loop Announces Senior Leadership Appointments and Changes

ACCESS Newswire

Press Release: Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones

CIBC Reaffirms Their Buy Rating on Pet Valu Holdings Ltd. (PET)

Pet Valu Holdings Ltd. (PET) Gets a Buy from Barclays

Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment

MT Newswires Live

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease

Lantheus Holdings Faces Uncertainty Amid Potential PET Scanner Shortage

CIBC Sticks to Its Buy Rating for Pet Valu Holdings Ltd. (PET)

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

Trust Stamp announces the allowance by USPTO of Non-Provisional Patent Application 17/725,978 entitled: “Interoperable Biometric Representation” unlocking the potential to break vendor lock-in for biometric services

Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection

Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million

Eight Specialty PET Resins From Eastman Receive RecyClass Approval

ACCESS Newswire

Stifel Nicolaus Remains a Hold on Pet Valu Holdings Ltd. (PET)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PET/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PET","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","market":"US","secType":"STK","nameCN":"Wag! Group Co","latestPrice":0.1281,"timestamp":1743710400000,"preClose":0.12,"halted":0,"volume":1010242,"delay":0,"floatShares":22064454,"shares":50733823,"eps":-0.392853,"marketStatus":"Pre-Market Trading","change":0.0081,"latestTime":"04-04 04:35:30 EDT","open":0.126,"high":0.163,"low":0.1068,"amount":133868.31909588,"amplitude":0.468333,"askPrice":0.2049,"askSize":200,"bidPrice":0.0999,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.392853,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743773400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1281,"postHourTrading":{"tag":"盘后","latestPrice":0.1394,"preClose":0.1281,"latestTime":"19:22 EDT","volume":20164,"amount":2767.5514,"timestamp":1743722551180},"volumeRatio":1.833826394539688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PET\",,,,,undefined,":{"symbol":"PET","floatShares":22064454,"roa":"-16.97%","roe":"-3036.82%","lyrEps":-0.392853,"volumeRatio":1.833826394539688,"shares":50733823,"dividePrice":0,"high":0.163,"amplitude":0.468333,"preClose":0.12,"low":0.1068,"week52Low":0.1068,"pbRate":"-13.29","psRate":"0.09","week52High":2.47,"institutionHeld":0,"latestPrice":0.1281,"committee":-0.333333,"eps":-0.392853,"divideRate":0,"volume":1010242,"delay":0,"ttmEps":-0.392853,"open":0.126,"prevYearClose":0.2383,"prevWeekClose":0.1716,"prevMonthClose":0.1531,"prevQuarterClose":0.1531,"fiveDayClose":0.187,"twentyDayClose":0.2525,"sixtyDayClose":0.2932},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PET\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520934434","title":"Wag! To Report Fourth Quarter and Full Year 2024 Financial Results on March 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520934434","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520934434?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:05","pubTimestamp":1742328300,"startTime":"0","endTime":"0","summary":"Group Co., (the “Company” or “Wag!”, Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modernU.S.pet household, today announced that it will report fourth quarter and full year 2024 financial results before market open on Monday, March 24, 2025. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results.Group Co.strives to be the number one platform to solve the service, product, and wellness needs of the modernU.S.pet household. Wag!pioneered on-demand dog walking in 2015 with the Wag!app, which offers access to 5-star dog walking, sitting, and one-on-one training from a community of over 500,000 Pet Caregivers nationwide. In addition,Wag!Group Co.operatesPetted, one of the nation’s largest pet insurance comparison marketplaces;Dog Food Advisor, one of the most visited and trusted pet food review platforms;WoofWoofTV, a multi-media company bringing delightful pet content to over 18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wag-report-fourth-quarter-full-200500285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PETWW","PET","BK4192"],"gpt_icon":0},{"id":"2520842426","title":"Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America","url":"https://stock-news.laohu8.com/highlight/detail?id=2520842426","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520842426?lang=en_us&edition=fundamental","pubTime":"2025-03-18 05:53","pubTimestamp":1742248380,"startTime":"0","endTime":"0","summary":"MELBOURNE,Australia andPORTO ALEGRE,Brazil, March 18, 2025  -- Telix Pharmaceuticals Limited  today announces that the Brazilian Health Regulatory Agency  has approved Illuccix  the Company’s lead prostate cancer imaging agent. Illuccix is the first and only PSMA-PET1 prostate cancer imaging agent to receive full regulatory approval in Brazil.Illuccix, after radiolabeling with 68Ga, is a radioactive diagnostic agent indicated for positron emission tomography  of prostate-specific membrane antigen  positive lesions in men with prostate cancer:. With suspected metastasis who are candidates for definitive initial therapy treatment, and. With suspected recurrence based on an elevated specific antigen  level in the serum.PSMA-PET is a diagnostic technology demonstrated to detect advanced prostate cancer. ANVISA becomes the latest regulatory body worldwide to approve Illuccix3, which is already commercially available in Australia, Canada, New Zealand and the United States, and has recently b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/illuccix-approved-prostate-cancer-imaging-215300352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["EEA","PET","SEC.AU","TLX","BK7039","ASX.AU","BK4213","BK4526","BK4528","TGA.AU","TLX.AU","BK4192","XJO.AU","BK4543","XKO.AU","PSA","BK4533","PET.AU","BK4588","BK4585","BK7001","ASX","BK7067","BK4141","UK","BK4144","TGA","DCP","BK4233","BK4139","BK4217","BK7047","XAO.AU","BK4205","BK4084"],"gpt_icon":0},{"id":"2519887682","title":"Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887682?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863600,"startTime":"0","endTime":"0","summary":"-- Landmark exclusive option and license deal with Takeda for ACI-24.060. with $100 million upfront and additional potential milestones of up to. about $2.1 billion plus royalties on sales upon commercialization. -- ACI-24.060 ABATE Phase 1b/2 trial showed encouraging interim safety and. tolerability data in Down syndrome  cohort; further interim results. in Alzheimer's disease  and DS expected in 2025. -- Enrollment progress in JNJ-2056  ReTain Phase 2b trial in. preclinical AD patients triggered second milestone payment of CHF 24.6. -- ACI-7104.056 VacSYn Phase 2 trial demonstrated positive interim safety. and immunogenicity results in Parkinson's disease ; further interim. \"The ability to innovate is key to our future success. Driven by our two drug discovery platforms, in 2024, we advanced multiple early-stage asse","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","IE00BVYPNV92.GBP","LU0640476718.USD","AAIC","LU0234572021.USD","IE0009355771.USD","LU1059921491.USD","ACIU","R","LU0098860793.USD","IE00BDGV0183.EUR","IE00B4R5TH58.HKD","LU0320765646.SGD","LU1032466523.USD","LU1162221912.USD","PD","BK4555","BK4604","JNJ","BK4592","ACI","IE00B2B36J28.USD","LU0345769128.USD","LU1169589451.USD","LU1506573853.SGD","LU0912757837.SGD","03160","IE00BSNM7G36.USD","LU2089984988.USD","BK4007","LU0792757196.USD","LU1244550577.SGD","PSP","LU1221951129.SGD","BK4532","LU1244550494.USD","LU2430703095.HKD","SG9999002224.SGD","IE000M9KFDE8.USD","LU1778281490.HKD","PET","LU0114720955.EUR","LU0234570918.USD","LU2505996509.AUD","CBD","ARIA","BK4581","IE00B42XCP33.USD","LU0203345920.USD","AC"],"gpt_icon":0},{"id":"2518877129","title":"Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518877129","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518877129?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:01","pubTimestamp":1741723260,"startTime":"0","endTime":"0","summary":"- Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP study; IND filing anticipated in 2026 - - Anti-tau antibody VY7523 was well","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040977/36461/en/Voyager-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-and-Operating-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSF","PET","CTA","BK4192"],"gpt_icon":0},{"id":"2518459727","title":"Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2518459727","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518459727?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:30","pubTimestamp":1741696200,"startTime":"0","endTime":"0","summary":"Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Chairman, Longeveron","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040564/0/en/Longeveron-Announces-Nature-Medicine-Publication-of-Results-of-Phase-2a-Clinical-Trial-Evaluating-Laromestrocel-Lomecel-B-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","PET","MSC","BK4218","LGVN","INN","BK4575","ARIA","BK4192","BK4150","BK4139"],"gpt_icon":0},{"id":"2517438301","title":"Loop Announces Senior Leadership Appointments and Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2517438301","media":"ACCESS Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517438301?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:00","pubTimestamp":1741352400,"startTime":"0","endTime":"0","summary":"MONTRAL, QUEBEC / ACCESS Newswire / March 7, 2025 / Loop Industries, Inc.  , a clean technology company dedicated to accelerating circular fashion by manufacturing 100% recycled polyethylene terephthalate  plastic and textile-to-textile polyester fiber, today announced the following senior leadership changes as it transitions to the next phase of its strategic development with the commercialization of its technology.Giovanni Catino, Vice President of Sales, is appointed Chief Revenue Officer, reflecting his leadership role in developing and implementing Loop's sales strategy with global apparel and food and beverage customers. Giovanni will play the lead role in building out our global supply chains, including the addition of polyester fiber as a product offering through partnerships with spinning companies. Giovanni will also sit on the board of the India JV with Ester Industries.Daniel Solomita, Founder and CEO of Loop, commented \"I am excited with the development of Adel and Giovann","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/loop-announces-senior-leadership-appointments-130000046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LOOP","BK4192","BK4090","PET"],"gpt_icon":0},{"id":"2517210118","title":"Press Release: Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2517210118","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517210118?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:05","pubTimestamp":1741295100,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones. - Topline data from PIPE-791 Phase 1b positron emission tomography  trial expected in the second quarter of 2025. - Topline data from PIPE-307 Phase 2 VISTA trial for the treatment of relapsing-remitting multiple sclerosis  anticipated in the second half of 2025. Contineum Therapeutics, Inc.  , a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology  indications, today reported its fourth-quarter 2024 financial results and affirmed its key clinical development milestones.\"2025 is shaping up to be a pivotal year, as we have several important clinical data readouts and trial initiations on the horizon,\" said Carmine Stengone, CEO, Contineum Therapeutics. \"We expect to be sponsoring up to six clinical trials during the course of the year, with key topline data from our PIPE-791 Phase 1b posi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNV92.GBP","IE00BFTCPJ56.SGD","BK4192","LU2129689514.USD","LU0792757196.USD","BK4007","IE0034235303.USD","LU0234570918.USD","LU1244550221.USD","LU1162221912.USD","JNJ","LU1061106388.HKD","LU2505996681.GBP","PET","LU1430594728.SGD","CTNM","LU1261432733.SGD","IE00B7SZLL34.SGD","LU0234572021.USD","IE0002141913.USD","LU2129689605.HKD","IE000M9KFDE8.USD","LU0345769631.USD","BK4585","LU0640476718.USD","IE00BVYPNW00.USD","LU0203347892.USD","LU1066053197.SGD","LU1244550494.USD","LU1244550577.SGD","LU0114720955.EUR","LU1914381329.SGD","IE0009355771.USD","LU0320765646.SGD","LU2592432038.USD","SG9999001440.SGD","LU1732800096.USD","LU0345769128.USD","LU0345770993.USD","LU2129689431.USD","BK4532","BK4504","IE00BSNM7G36.USD","LU1778281490.HKD","LU1267930813.SGD","LU2430703095.HKD","BK4550","LENZ","LU1196500208.SGD","BK4559"],"gpt_icon":0},{"id":"2517894532","title":"CIBC Reaffirms Their Buy Rating on Pet Valu Holdings Ltd. (PET)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517894532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517894532?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:07","pubTimestamp":1741187247,"startTime":"0","endTime":"0","summary":"CIBC analyst Mark Petrie maintained a Buy rating on Pet Valu Holdings Ltd. (PET – Research Report) today and set a price target of C$33.00. The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cibc-reaffirms-their-buy-rating-on-pet-valu-holdings-ltd-pet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cibc-reaffirms-their-buy-rating-on-pet-valu-holdings-ltd-pet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PET"],"gpt_icon":0},{"id":"2517917459","title":"Pet Valu Holdings Ltd. (PET) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2517917459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517917459?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:42","pubTimestamp":1741167771,"startTime":"0","endTime":"0","summary":"Barclays analyst Adrienne Yih maintained a Buy rating on Pet Valu Holdings Ltd. (PET – Research Report) today and set a price target of C$32.00. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pet-valu-holdings-ltd-pet-gets-a-buy-from-barclays-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pet-valu-holdings-ltd-pet-gets-a-buy-from-barclays-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","PET"],"gpt_icon":0},{"id":"2516657210","title":"Voyager Therapeutics Reports Positive Trial Results From Alzheimer's Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2516657210","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516657210?lang=en_us&edition=fundamental","pubTime":"2025-03-04 03:27","pubTimestamp":1741030053,"startTime":"0","endTime":"0","summary":"Voyager Therapeutics  reported positive results Monday from the single ascending dose trial of its investigational antibody VY7523, developed to selectively inhibit the spread of pathological tau in Alzheimer's disease.Data from the trial demonstrated the safety, tolerability, and dose-proportional pharmacokinetics of single intravenous doses in 48 healthy volunteers, the company said.The drug was well tolerated across all six ascending dose cohorts, meeting the primary objective of the trial, with no serious adverse events, severe adverse events, or infusion reactions reported.Voyager said it has initiated a multiple ascending dose trial of the drug in patients with early Alzheimer's disease, which is expected to generate initial tau positron emission tomography  imaging data in H2 2026.Voyager shares were down nearly 3% in recent trading.Price: 3.97, Change: -0.11, Percent Change: -2.70","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4192","BK7047","VYGR","PET.AU","BK4139","PET"],"gpt_icon":0},{"id":"2516463830","title":"Cassava Sciences Reports 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2516463830","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516463830?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:30","pubTimestamp":1741005000,"startTime":"0","endTime":"0","summary":"Top-line data for REFOCUS-ALZ, the second Phase 3 study of simufilam in Alzheimer’s disease, expected late first-quarter/early second-quarter 2025License agreement brings potential in a new therapeuti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035508/8339/en/Cassava-Sciences-Reports-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","PET","BK4007","ETH","BK4601","CNS","BK4585","BK4192","BK4547","BK4588","SAVA"],"gpt_icon":0},{"id":"2516877576","title":"Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2516877576","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516877576?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"- Topline SAD data from healthy volunteers demonstrate safety, tolerability, and dose-proportional pharmacokinetics, supporting potentially best-in-class profile - - MAD study initiated in patients wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035441/36461/en/Voyager-Reports-Positive-Topline-Data-for-Single-Ascending-Dose-SAD-Trial-of-Anti-Tau-Antibody-VY7523-and-Initiates-Multiple-Ascending-Dose-MAD-Trial-in-Alzheimer-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","CSF","PET","PK","BK4218","BK4192"],"gpt_icon":0},{"id":"2514672842","title":"Lantheus Holdings Faces Uncertainty Amid Potential PET Scanner Shortage","url":"https://stock-news.laohu8.com/highlight/detail?id=2514672842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514672842?lang=en_us&edition=fundamental","pubTime":"2025-02-27 14:01","pubTimestamp":1740636068,"startTime":"0","endTime":"0","summary":"Lantheus Holdings Inc (LNTH) has disclosed a new risk, in the Technology category. Lantheus Holdings Inc. faces a significant business risk due to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lantheus-holdings-faces-uncertainty-amid-potential-pet-scanner-shortage?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lantheus-holdings-faces-uncertainty-amid-potential-pet-scanner-shortage?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNTH","BK4192","BK4588","BK4198","BK4585","PET"],"gpt_icon":0},{"id":"2514689038","title":"CIBC Sticks to Its Buy Rating for Pet Valu Holdings Ltd. (PET)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514689038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514689038?lang=en_us&edition=fundamental","pubTime":"2025-02-27 00:46","pubTimestamp":1740588377,"startTime":"0","endTime":"0","summary":"In a report released today, Mark Petrie from CIBC maintained a Buy rating on Pet Valu Holdings Ltd. (PET – Research Report), with a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cibc-sticks-to-its-buy-rating-for-pet-valu-holdings-ltd-pet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cibc-sticks-to-its-buy-rating-for-pet-valu-holdings-ltd-pet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PET"],"gpt_icon":0},{"id":"2514839972","title":"Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839972","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839972?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"Worldwide revenue of $391.1 million and $1.53 billion for the fourth quarter and full year 2024. Free cash flow was $141.4 million and $493.1 million for the fourth quarter and full year 2024. GAAP fully diluted loss per share of $ and earnings per share of $4.36 for the fourth quarter and full year 2024. Adjusted fully diluted earnings per share of $1.59 and $6.76 for the fourth quarter and full year 2024. PYLARIFY exceeds $1 billion in net sales and becomes first ever blockbuster radiodiagnostic. Company announces a series of strategic asset and in-licensing deals that is expected to diversify its portfolio with early- to late-stage assets that position the company for continued growth in high potential markets. Company provides full year 2025 revenue and adjusted diluted earnings per share guidance. Operating income decreased 17.2% to $113.9 million. Adjusted operating income  decreased 8.4% to $151.8 million.At December 31, 2024, the Company's cash and cash equivalents grew to $912","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantheus-reports-fourth-quarter-full-120000001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LNTH","PET","LU1894683348.USD","BK4588","BK4198","LU2637428348.USD","BK4192","BK4585","BK4208","LU2346227817.USD","CMS","LU1894683264.USD"],"gpt_icon":0},{"id":"2514716097","title":"Trust Stamp announces the allowance by USPTO of Non-Provisional Patent Application 17/725,978 entitled: “Interoperable Biometric Representation” unlocking the potential to break vendor lock-in for biometric services","url":"https://stock-news.laohu8.com/highlight/detail?id=2514716097","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514716097?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:30","pubTimestamp":1740493800,"startTime":"0","endTime":"0","summary":"Atlanta, GA, Feb.  25, 2025  (GLOBE NEWSWIRE) -- Trust Stamp announces a groundbreaking innovation in biometric security with the allowance by the United States Patent and Trademark Office of a patent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/25/3032149/0/en/Trust-Stamp-announces-the-allowance-by-USPTO-of-Non-Provisional-Patent-Application-17-725-978-entitled-Interoperable-Biometric-Representation-unlocking-the-potential-to-break-vendo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PET","BK4192"],"gpt_icon":0},{"id":"2514090637","title":"Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090637","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514090637?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:00","pubTimestamp":1740492000,"startTime":"0","endTime":"0","summary":"The first patient doses of GE HealthCare’s new FDA-approved PET radiotracer, Flyrcado  injection, are being administered at early adopter sites around the United States.Available as a ready-to-use unit dose, Flyrcado can expand clinician and patient access to PET MPI and is expected to be available to nearly all of the existing cardiac PET centers in the US by the end of 2025.This month, Houston Methodist Hospital delivered the first doses in a phased rollout of the cardiac PET agent at early adopter imaging centers nationwide, which includes UW Health University Hospital in Wisconsin. Full commercialization of the radiotracer is anticipated in the second quarter of 2025. With a half-life of 109 minutes—significantly longer than existing PET MPI tracers—Flyrcado removes the need for on-site tracer production and generator maintenance and enables distribution to a wide network of hospitals and imaging centers. GE HealthCare will be supported by contract manufacturing organizations  to e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/patients-us-undergo-first-doses-140000945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMS","BK4588","LU0149725797.USD","BK4187","LU1064131342.USD","BK4082","LU0868494617.USD","LU0689472784.USD","LU2346227817.USD","LU0354030438.USD","LU2264538146.SGD","BK4585","LU1280957306.USD","LU1894683348.USD","LU0640476718.USD","LU1551013342.USD","LU1988902786.USD","LU0943347566.SGD","LU0820561818.USD","LU2756315664.SGD","LU0689626769.HKD","LU1093756325.SGD","LU0820562030.AUD","BK4543","LU1366333091.USD","LU2637428348.USD","BK4501","LU1261432733.SGD","PET","BK4208","BK4192","LU1894683264.USD","GEHC","BK4206","LU1551013425.SGD","BK4566","LU2756315318.SGD","LU0354030511.USD","LU0820561909.HKD","LU0157215616.USD","LU0124676726.USD","GE","LU1093756168.USD"],"gpt_icon":0},{"id":"2514037197","title":"Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514037197","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514037197?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:30","pubTimestamp":1740429039,"startTime":"0","endTime":"0","summary":"A number of ASX-listed healthcare companies, many with relatively low market caps, are making strides in tackling cancer. Imagion is aiming to revolutionise cancer diagnosis by introducing molecular imaging to magnetic resonance imaging . Headed by drug discovery leader Dr Chris Burns, Amplia is advancing a pipeline of Focal Adhesion Kinase  inhibitors for cancer and fibrosis","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-185077562-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-185077562-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/bargain-barrel-four-asx-cancer-fighting-stocks-with-market-caps-under-35-million/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["PET","PDT","ASCC","BK4169","BK4192"],"gpt_icon":0},{"id":"2513007727","title":"Eight Specialty PET Resins From Eastman Receive RecyClass Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2513007727","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513007727?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:45","pubTimestamp":1740408300,"startTime":"0","endTime":"0","summary":"Eastman copolyester resins earn RecyClass Approval, with six grades fully compatible with Europe's PET bottle recycling processes.KINGSPORT, TN / ACCESS Newswire / February 24, 2025 / Eastman has received RecyClass Recyclability Approvals for its specialty PET resins and their equivalent Renew grades, containing recycled content.Six specialty plastics were classified as fully compatible with the state-of-the-art recycling processes for PET bottles in Europe. This includes:. Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company's innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eight-specialty-pet-resins-eastman-144500198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1066053197.SGD","BK4599","BK4592","EMN","LU0868494617.USD","BK4581","LU0306806265.USD","LU0234572021.USD","LU0321505439.SGD","LU0306807586.USD","BK4568","BK4533","LU0122379950.USD","SG9999001176.SGD","SG9999002232.USD","BK4585","IE00BLSP4239.USD","LU1066051498.USD","BK4550","LU1894683264.USD","LU1894683348.USD","PET","LU1883839398.USD","SG9999002224.SGD","BK4098","BK4534","BK4588","SG9999003800.SGD","SG9999013999.USD","LU0225284248.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4007","LU0321505868.SGD","IE00BLSP4452.SGD","LU0456855351.SGD","IE00B19Z3B42.SGD","LU0170899867.USD","BK4192","IE0002270589.USD","LU0289739699.SGD","LU0985481810.HKD","IE000M9KFDE8.USD","BK4109","LU0225771236.USD","SGXZ57979304.SGD","SG9999011175.SGD","LU0058720904.USD","SG9999001176.USD"],"gpt_icon":1},{"id":"2513726503","title":"Stifel Nicolaus Remains a Hold on Pet Valu Holdings Ltd. (PET)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726503?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:06","pubTimestamp":1740402392,"startTime":"0","endTime":"0","summary":"In a report released today, Martin Landry from Stifel Nicolaus maintained a Hold rating on Pet Valu Holdings Ltd. (PET – Research Report), with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-hold-on-pet-valu-holdings-ltd-pet-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-hold-on-pet-valu-holdings-ltd-pet-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","BK4127","PET","SF"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":123}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PET\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-24","symbol":"PET","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2024-11-13","symbol":"PET","fiscalQuarterEnding":"2024/09","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-08-07","symbol":"PET","fiscalQuarterEnding":"2024/06","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.06},{"date":"2024-07-10","symbol":"PET","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1720598400000,"name":null,"time":"Pre-Market","dateTimestamp":1720584000000,"actualEps":null},{"market":"US","date":"2024-05-09","symbol":"PET","fiscalQuarterEnding":"2024/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PET\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PET\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1731643200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PET\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PET","date":"2025-04-03","current":-0.346542,"percent":1,"low":-51.918761,"twenty":-24.608818,"median":-4.659207,"eighty":-1.929159,"high":-0.346542,"avg":-10.359671,"sd":10.939886,"marketCap":6088058},"quantilePoints":[{"date":"2021-10-01","current":-7.916755,"twenty":-7.916755,"median":-7.908627,"eighty":-7.901458,"marketCap":149143750},{"date":"2021-10-08","current":-7.941139,"twenty":-7.942895,"median":-7.928947,"eighty":-7.908627,"marketCap":149603125},{"date":"2021-10-15","current":-7.900499,"twenty":-7.941172,"median":-7.916755,"eighty":-7.900499,"marketCap":148837500},{"date":"2021-10-22","current":-7.908627,"twenty":-7.941139,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-10-29","current":-7.908627,"twenty":-7.934637,"median":-7.908627,"eighty":-7.900499,"marketCap":148990625},{"date":"2021-11-05","current":-7.941139,"twenty":-7.941139,"median":-7.916755,"eighty":-7.900499,"marketCap":149603125},{"date":"2021-11-12","current":-7.949267,"twenty":-7.941139,"median":-7.924883,"eighty":-7.907001,"marketCap":149756250},{"date":"2021-11-19","current":-7.965524,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":150062500},{"date":"2021-11-26","current":-8.185579,"twenty":-7.949267,"median":-7.933011,"eighty":-7.908627,"marketCap":154208125},{"date":"2021-12-03","current":-8.143943,"twenty":-7.965524,"median":-7.941139,"eighty":-7.908627,"marketCap":153423750},{"date":"2021-12-10","current":-8.110635,"twenty":-8.123958,"median":-7.941139,"eighty":-7.908627,"marketCap":152796250},{"date":"2021-12-17","current":-8.111634,"twenty":-8.143943,"median":-7.941139,"eighty":-7.908627,"marketCap":152815075},{"date":"2021-12-23","current":-8.135616,"twenty":-8.143943,"median":-7.949267,"eighty":-7.908627,"marketCap":153266875},{"date":"2021-12-31","current":-8.143943,"twenty":-8.143943,"median":-7.949267,"eighty":-7.911878,"marketCap":153423750},{"date":"2022-01-07","current":-25.77251,"twenty":-8.143943,"median":-7.957396,"eighty":-7.916755,"marketCap":153423750},{"date":"2022-01-14","current":-25.746157,"twenty":-8.168925,"median":-7.965524,"eighty":-7.916755,"marketCap":153266875},{"date":"2022-01-21","current":-25.746157,"twenty":-8.185579,"median":-7.977716,"eighty":-7.918381,"marketCap":153266875},{"date":"2022-01-28","current":-25.746157,"twenty":-25.693453,"median":-8.111634,"eighty":-7.924883,"marketCap":153266875},{"date":"2022-02-04","current":-25.825214,"twenty":-25.746157,"median":-8.115298,"eighty":-7.926509,"marketCap":153737500},{"date":"2022-02-11","current":-25.956975,"twenty":-25.746157,"median":-8.135616,"eighty":-7.933011,"marketCap":154521875},{"date":"2022-02-18","current":-25.904271,"twenty":-25.746157,"median":-8.143943,"eighty":-7.933011,"marketCap":154208125},{"date":"2022-02-25","current":-25.851566,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":153894375},{"date":"2022-03-04","current":-25.930623,"twenty":-25.77251,"median":-8.143943,"eighty":-7.933011,"marketCap":154365000},{"date":"2022-03-11","current":-25.956975,"twenty":-25.825214,"median":-8.143943,"eighty":-7.941139,"marketCap":154521875},{"date":"2022-03-18","current":-26.115089,"twenty":-25.825214,"median":-8.160598,"eighty":-7.941139,"marketCap":155463125},{"date":"2022-03-25","current":-26.036032,"twenty":-25.851566,"median":-8.177252,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-01","current":-26.036032,"twenty":-25.877919,"median":-8.185579,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-08","current":-26.036032,"twenty":-25.904271,"median":-16.939516,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-14","current":-26.220498,"twenty":-25.956975,"median":-25.700041,"eighty":-7.941139,"marketCap":156090625},{"date":"2022-04-22","current":-26.036032,"twenty":-25.956975,"median":-25.746157,"eighty":-7.941139,"marketCap":154992500},{"date":"2022-04-29","current":-26.088737,"twenty":-26.00968,"median":-25.746157,"eighty":-7.941269,"marketCap":155306250},{"date":"2022-05-06","current":-26.036032,"twenty":-26.01495,"median":-25.746157,"eighty":-7.947674,"marketCap":154992500},{"date":"2022-05-13","current":-24.509388,"twenty":-26.01495,"median":-25.746157,"eighty":-7.949267,"marketCap":154678750},{"date":"2022-05-20","current":-24.534246,"twenty":-26.00968,"median":-25.746157,"eighty":-7.949267,"marketCap":154835625},{"date":"2022-05-27","current":-24.68339,"twenty":-26.00968,"median":-25.719805,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-03","current":-24.68339,"twenty":-26.00968,"median":-25.693453,"eighty":-7.949267,"marketCap":155776875},{"date":"2022-06-10","current":-24.583961,"twenty":-26.00968,"median":-24.68339,"eighty":-7.954144,"marketCap":155149375},{"date":"2022-06-17","current":-24.608818,"twenty":-26.00968,"median":-24.68339,"eighty":-7.957396,"marketCap":155306250},{"date":"2022-06-24","current":-24.708248,"twenty":-25.988598,"median":-24.68339,"eighty":-7.960647,"marketCap":155933750},{"date":"2022-07-01","current":-24.608818,"twenty":-25.956975,"median":-24.658533,"eighty":-7.965524,"marketCap":155306250},{"date":"2022-07-08","current":-24.733105,"twenty":-25.956975,"median":-24.658533,"eighty":-7.96715,"marketCap":156090625},{"date":"2022-07-15","current":-24.757962,"twenty":-25.956975,"median":-24.68339,"eighty":-7.975278,"marketCap":156247500},{"date":"2022-07-22","current":-24.807677,"twenty":-25.956975,"median":-24.68339,"eighty":-8.007551,"marketCap":156561250},{"date":"2022-07-29","current":-25.105966,"twenty":-25.956975,"median":-24.68339,"eighty":-8.110835,"marketCap":158443750},{"date":"2022-08-05","current":-19.587625,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":123617500},{"date":"2022-08-12","current":-46.571248,"twenty":-25.956975,"median":-24.68339,"eighty":-8.111634,"marketCap":293911149},{"date":"2022-08-19","current":-31.187311,"twenty":-26.00968,"median":-24.68339,"eighty":-8.1131,"marketCap":196823120},{"date":"2022-08-26","current":-29.685032,"twenty":-26.00968,"median":-24.708248,"eighty":-8.118962,"marketCap":187342238},{"date":"2022-09-02","current":-34.550721,"twenty":-26.036032,"median":-24.733105,"eighty":-8.122293,"marketCap":159278826},{"date":"2022-09-09","current":-42.365766,"twenty":-26.036032,"median":-24.757962,"eighty":-8.135616,"marketCap":195306179},{"date":"2022-09-16","current":-44.175565,"twenty":-26.036032,"median":-24.78282,"eighty":-8.135616,"marketCap":203649356},{"date":"2022-09-23","current":-20.154587,"twenty":-26.036032,"median":-24.78282,"eighty":-8.143943,"marketCap":92912648},{"date":"2022-09-30","current":-16.864043,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":77743236},{"date":"2022-10-07","current":-20.812696,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":95946530},{"date":"2022-10-14","current":-24.020978,"twenty":-26.036032,"median":-24.708248,"eighty":-8.143943,"marketCap":110736707},{"date":"2022-10-21","current":-32.45159,"twenty":-26.036032,"median":-24.733105,"eighty":-8.143943,"marketCap":149601831},{"date":"2022-10-28","current":-34.873351,"twenty":-26.036032,"median":-24.745534,"eighty":-8.143943,"marketCap":160766146},{"date":"2022-11-04","current":-27.317458,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":125933481},{"date":"2022-11-11","current":-2.304056,"twenty":-26.115089,"median":-24.78282,"eighty":-8.143943,"marketCap":108509519},{"date":"2022-11-18","current":-2.038504,"twenty":-26.115089,"median":-24.757962,"eighty":-8.143943,"marketCap":96003337},{"date":"2022-11-25","current":-1.9604,"twenty":-26.115089,"median":-24.733105,"eighty":-8.132285,"marketCap":92325048},{"date":"2022-12-02","current":-1.991642,"twenty":-26.094007,"median":-24.708248,"eighty":-8.111634,"marketCap":93796364},{"date":"2022-12-09","current":-1.62846,"twenty":-26.046573,"median":-24.68339,"eighty":-7.972026,"marketCap":76692321},{"date":"2022-12-16","current":-1.679227,"twenty":-26.036032,"median":-24.68339,"eighty":-7.95577,"marketCap":79083209},{"date":"2022-12-23","current":-2.436832,"twenty":-26.036032,"median":-24.658533,"eighty":-7.949267,"marketCap":114762610},{"date":"2022-12-30","current":-2.405591,"twenty":-26.036032,"median":-24.658533,"eighty":-7.941139,"marketCap":113291295},{"date":"2023-01-06","current":-2.069667,"twenty":-26.036032,"median":-24.633675,"eighty":-7.941139,"marketCap":97470974},{"date":"2023-01-13","current":-2.218142,"twenty":-26.036032,"median":-24.621246,"eighty":-7.933011,"marketCap":104463401},{"date":"2023-01-20","current":-2.17128,"twenty":-26.036032,"median":-24.608818,"eighty":-7.926509,"marketCap":102256428},{"date":"2023-01-27","current":-2.530556,"twenty":-26.036032,"median":-24.608818,"eighty":-7.916755,"marketCap":119176557},{"date":"2023-02-03","current":-2.155659,"twenty":-26.036032,"median":-24.608818,"eighty":-7.908627,"marketCap":101520770},{"date":"2023-02-10","current":-1.851055,"twenty":-26.036032,"median":-24.608818,"eighty":-7.902125,"marketCap":87175444},{"date":"2023-02-17","current":-1.874486,"twenty":-26.036032,"median":-24.571532,"eighty":-7.893997,"marketCap":88278931},{"date":"2023-02-24","current":-2.245322,"twenty":-26.036032,"median":-24.559103,"eighty":-2.530556,"marketCap":86595328},{"date":"2023-03-03","current":-2.245322,"twenty":-26.036032,"median":-24.534246,"eighty":-2.452453,"marketCap":86595328},{"date":"2023-03-10","current":-1.614721,"twenty":-26.036032,"median":-24.534246,"eighty":-2.413401,"marketCap":62274938},{"date":"2023-03-17","current":-1.94913,"twenty":-26.036032,"median":-24.534246,"eighty":-2.38997,"marketCap":75172115},{"date":"2023-03-24","current":-2.197549,"twenty":-26.036032,"median":-24.509388,"eighty":-2.340867,"marketCap":84752874},{"date":"2023-03-31","current":-2.140222,"twenty":-26.036032,"median":-24.020978,"eighty":-2.293095,"marketCap":82541930},{"date":"2023-04-06","current":-2.111558,"twenty":-26.036032,"median":-23.445132,"eighty":-2.245322,"marketCap":81436457},{"date":"2023-04-14","current":-2.159331,"twenty":-26.036032,"median":-22.561,"eighty":-2.225952,"marketCap":83278911},{"date":"2023-04-21","current":-2.203009,"twenty":-26.01495,"median":-21.964387,"eighty":-2.217056,"marketCap":84963432},{"date":"2023-04-28","current":-2.270943,"twenty":-26.00968,"median":-20.697308,"eighty":-2.210332,"marketCap":87583450},{"date":"2023-05-05","current":-2.021661,"twenty":-26.00968,"median":-19.99006,"eighty":-2.209686,"marketCap":77969386},{"date":"2023-05-12","current":-2.248784,"twenty":-26.00968,"median":-19.907797,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-19","current":-2.248784,"twenty":-26.00968,"median":-19.587625,"eighty":-2.209686,"marketCap":89960352},{"date":"2023-05-26","current":-1.874257,"twenty":-26.00968,"median":-19.301764,"eighty":-2.197549,"marketCap":74977784},{"date":"2023-06-02","current":-2.174138,"twenty":-25.978057,"median":-18.097997,"eighty":-2.197549,"marketCap":86974229},{"date":"2023-06-09","current":-2.061683,"twenty":-25.956975,"median":-16.864043,"eighty":-2.186237,"marketCap":82475562},{"date":"2023-06-16","current":-2.127282,"twenty":-25.956975,"median":-8.185579,"eighty":-2.180933,"marketCap":85099784},{"date":"2023-06-23","current":-2.04294,"twenty":-25.956975,"median":-8.185579,"eighty":-2.17128,"marketCap":81725784},{"date":"2023-06-29","current":-1.958599,"twenty":-25.956975,"median":-8.185579,"eighty":-2.164767,"marketCap":78351784},{"date":"2023-07-07","current":-1.883628,"twenty":-25.956975,"median":-8.168925,"eighty":-2.16347,"marketCap":75352672},{"date":"2023-07-14","current":-1.893,"twenty":-25.956975,"median":-8.148107,"eighty":-2.155659,"marketCap":75727561},{"date":"2023-07-21","current":-2.04294,"twenty":-25.956975,"median":-8.143943,"eighty":-2.147849,"marketCap":81725784},{"date":"2023-07-28","current":-2.108539,"twenty":-25.956975,"median":-8.143943,"eighty":-2.139508,"marketCap":84350007},{"date":"2023-08-04","current":-2.267851,"twenty":-25.941164,"median":-8.143943,"eighty":-2.138794,"marketCap":90723118},{"date":"2023-08-11","current":-2.32208,"twenty":-25.920074,"median":-8.135616,"eighty":-2.137501,"marketCap":99345563},{"date":"2023-08-18","current":-2.075795,"twenty":-25.907779,"median":-8.118962,"eighty":-2.137501,"marketCap":88808739},{"date":"2023-08-25","current":-2.053134,"twenty":-25.904271,"median":-8.111634,"eighty":-2.127997,"marketCap":87839211},{"date":"2023-09-01","current":-1.840115,"twenty":-25.904271,"median":-8.046207,"eighty":-2.121113,"marketCap":78725651},{"date":"2023-09-08","current":-1.903567,"twenty":-25.903322,"median":-7.973652,"eighty":-2.112829,"marketCap":81440328},{"date":"2023-09-15","current":-1.758534,"twenty":-25.899527,"median":-7.965524,"eighty":-2.108539,"marketCap":75235351},{"date":"2023-09-22","current":-1.695082,"twenty":-25.877919,"median":-7.953331,"eighty":-2.093176,"marketCap":72520673},{"date":"2023-09-29","current":-1.740405,"twenty":-25.851566,"median":-7.949267,"eighty":-2.080425,"marketCap":74459729},{"date":"2023-10-06","current":-1.704146,"twenty":-25.851566,"median":-7.945284,"eighty":-2.069745,"marketCap":72908484},{"date":"2023-10-13","current":-1.676952,"twenty":-25.851566,"median":-7.941139,"eighty":-2.061683,"marketCap":71745051},{"date":"2023-10-20","current":-1.60933,"twenty":-25.851566,"median":-7.941139,"eighty":-2.052312,"marketCap":68851980},{"date":"2023-10-27","current":-1.568177,"twenty":-25.851566,"median":-7.941139,"eighty":-2.045204,"marketCap":67091318},{"date":"2023-11-03","current":-1.560563,"twenty":-25.851566,"median":-7.933011,"eighty":-2.038504,"marketCap":66765557},{"date":"2023-11-10","current":-16.478139,"twenty":-25.851566,"median":-7.933011,"eighty":-2.036475,"marketCap":66703507},{"date":"2023-11-17","current":-17.055401,"twenty":-25.841025,"median":-7.941139,"eighty":-2.038504,"marketCap":69040264},{"date":"2023-11-24","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.038504,"marketCap":69071661},{"date":"2023-12-01","current":-17.063157,"twenty":-25.825214,"median":-7.941139,"eighty":-2.039391,"marketCap":69071661},{"date":"2023-12-08","current":-16.966208,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68679208},{"date":"2023-12-15","current":-16.869258,"twenty":-25.825214,"median":-7.949267,"eighty":-2.04294,"marketCap":68286755},{"date":"2023-12-22","current":-17.257057,"twenty":-25.819944,"median":-7.957396,"eighty":-2.044072,"marketCap":69856566},{"date":"2023-12-29","current":-16.966208,"twenty":-25.804132,"median":-7.96146,"eighty":-2.047469,"marketCap":68679208},{"date":"2024-01-05","current":-17.063157,"twenty":-25.798862,"median":-7.965524,"eighty":-2.050085,"marketCap":69071661},{"date":"2024-01-12","current":-16.384509,"twenty":-25.798862,"median":-8.046207,"eighty":-2.052312,"marketCap":66324492},{"date":"2024-01-19","current":-17.450956,"twenty":-25.793592,"median":-8.111634,"eighty":-2.052312,"marketCap":70641471},{"date":"2024-01-26","current":-19.293002,"twenty":-25.77251,"median":-8.118962,"eighty":-2.052476,"marketCap":78098071},{"date":"2024-02-02","current":-19.370562,"twenty":-25.77251,"median":-8.135616,"eighty":-2.054844,"marketCap":78412033},{"date":"2024-02-09","current":-17.935705,"twenty":-25.77251,"median":-8.143943,"eighty":-2.061683,"marketCap":72603734},{"date":"2024-02-16","current":-6.45394,"twenty":-25.77251,"median":-8.143943,"eighty":-2.06328,"marketCap":85947123},{"date":"2024-02-23","current":-5.95295,"twenty":-25.77251,"median":-8.139779,"eighty":-2.069667,"marketCap":79275429},{"date":"2024-03-01","current":-5.894009,"twenty":-25.77251,"median":-8.118962,"eighty":-2.069745,"marketCap":78490524},{"date":"2024-03-08","current":-6.33606,"twenty":-25.746157,"median":-8.111634,"eighty":-2.069745,"marketCap":84377313},{"date":"2024-03-15","current":-6.12977,"twenty":-25.746157,"median":-8.110635,"eighty":-2.075795,"marketCap":81630144},{"date":"2024-03-22","current":-5.894009,"twenty":-25.746157,"median":-7.969588,"eighty":-2.077556,"marketCap":78490524},{"date":"2024-03-28","current":-5.658249,"twenty":-25.746157,"median":-7.96146,"eighty":-2.077556,"marketCap":75350903},{"date":"2024-04-05","current":-6.089301,"twenty":-25.746157,"median":-7.949267,"eighty":-2.079851,"marketCap":81091218},{"date":"2024-04-12","current":-6.392251,"twenty":-25.746157,"median":-7.949267,"eighty":-2.080425,"marketCap":85125607},{"date":"2024-04-19","current":-6.301366,"twenty":-25.746157,"median":-7.941302,"eighty":-2.084378,"marketCap":83915291},{"date":"2024-04-26","current":-6.664906,"twenty":-25.746157,"median":-7.941139,"eighty":-2.091032,"marketCap":88756558},{"date":"2024-05-03","current":-6.831529,"twenty":-25.746157,"median":-7.941139,"eighty":-2.093031,"marketCap":90975471},{"date":"2024-05-10","current":-7.133641,"twenty":-25.746157,"median":-7.937075,"eighty":-2.09797,"marketCap":98237372},{"date":"2024-05-17","current":-5.947142,"twenty":-25.746157,"median":-7.933011,"eighty":-2.099168,"marketCap":81898096},{"date":"2024-05-24","current":-4.687403,"twenty":-25.735616,"median":-7.924883,"eighty":-2.106665,"marketCap":64550224},{"date":"2024-05-31","current":-4.572017,"twenty":-25.71717,"median":-7.916755,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-07","current":-4.572017,"twenty":-25.698723,"median":-7.908627,"eighty":-2.108539,"marketCap":62961251},{"date":"2024-06-14","current":-4.513024,"twenty":-25.693453,"median":-7.908627,"eighty":-2.108642,"marketCap":62148847},{"date":"2024-06-21","current":-4.365539,"twenty":-25.580927,"median":-7.908627,"eighty":-2.109349,"marketCap":60117839},{"date":"2024-06-28","current":-4.92598,"twenty":-25.355875,"median":-7.908627,"eighty":-2.110454,"marketCap":67835670},{"date":"2024-07-05","current":-4.719502,"twenty":-25.12088,"median":-7.900499,"eighty":-2.114099,"marketCap":64992259},{"date":"2024-07-12","current":-4.45403,"twenty":-24.996593,"median":-7.900499,"eighty":-2.119192,"marketCap":61336444},{"date":"2024-07-15","current":-4.719502,"twenty":-24.941907,"median":-7.900499,"eighty":-2.119832,"marketCap":64992259},{"date":"2024-08-02","current":-3.480633,"twenty":-24.88722,"median":-7.896435,"eighty":-2.120473,"marketCap":47931791},{"date":"2024-08-09","current":-3.44267,"twenty":-24.832534,"median":-7.872782,"eighty":-2.121113,"marketCap":41838766},{"date":"2024-08-16","current":-3.734947,"twenty":-24.812648,"median":-6.984832,"eighty":-2.126048,"marketCap":45390806},{"date":"2024-08-23","current":-3.084343,"twenty":-24.807677,"median":-6.876972,"eighty":-2.127282,"marketCap":37484020},{"date":"2024-08-30","current":-3.413661,"twenty":-24.787791,"median":-6.869398,"eighty":-2.127282,"marketCap":41486221},{"date":"2024-09-06","current":-3.375508,"twenty":-24.78282,"median":-6.801234,"eighty":-2.127997,"marketCap":41022551},{"date":"2024-09-13","current":-2.972696,"twenty":-24.767905,"median":-6.725496,"eighty":-2.129789,"marketCap":36127177},{"date":"2024-09-20","current":-3.449806,"twenty":-24.757962,"median":-6.635604,"eighty":-2.134259,"marketCap":41925487},{"date":"2024-09-27","current":-3.545388,"twenty":-24.743048,"median":-6.543726,"eighty":-2.136653,"marketCap":43087101},{"date":"2024-10-04","current":-3.48595,"twenty":-24.733105,"median":-6.48341,"eighty":-2.137501,"marketCap":42364752},{"date":"2024-10-11","current":-3.353821,"twenty":-24.733105,"median":-6.45394,"eighty":-2.13936,"marketCap":40758992},{"date":"2024-10-18","current":-3.413661,"twenty":-24.718191,"median":-6.392251,"eighty":-2.140222,"marketCap":41486221},{"date":"2024-10-25","current":-3.226914,"twenty":-24.708248,"median":-6.361956,"eighty":-2.143518,"marketCap":39216680},{"date":"2024-10-31","current":-2.961451,"twenty":-24.708248,"median":-6.331661,"eighty":-2.146569,"marketCap":35990517},{"date":"2024-11-08","current":-2.552615,"twenty":-24.698305,"median":-6.303978,"eighty":-2.147849,"marketCap":31021931},{"date":"2024-11-15","current":-0.547386,"twenty":-24.68339,"median":-6.27712,"eighty":-2.146569,"marketCap":8878051},{"date":"2024-11-22","current":-0.606003,"twenty":-24.68339,"median":-6.22989,"eighty":-2.137218,"marketCap":9828767},{"date":"2024-11-29","current":-0.659113,"twenty":-24.68339,"median":-6.184448,"eighty":-2.128912,"marketCap":10690153},{"date":"2024-12-06","current":-0.685514,"twenty":-24.68339,"median":-6.12977,"eighty":-2.122347,"marketCap":11118357},{"date":"2024-12-13","current":-0.70639,"twenty":-24.678419,"median":-6.080065,"eighty":-2.109349,"marketCap":11456936},{"date":"2024-12-20","current":-0.621353,"twenty":-24.658533,"median":-6.04136,"eighty":-2.101042,"marketCap":10077722},{"date":"2024-12-27","current":-0.728186,"twenty":-24.658533,"median":-6.035031,"eighty":-2.092449,"marketCap":11810453},{"date":"2025-01-03","current":-0.874929,"twenty":-24.658533,"median":-6.01189,"eighty":-2.079851,"marketCap":14190469},{"date":"2025-01-10","current":-0.83195,"twenty":-24.658533,"median":-5.968121,"eighty":-2.073375,"marketCap":13493393},{"date":"2025-01-17","current":-0.801251,"twenty":-24.643618,"median":-5.93531,"eighty":-2.061683,"marketCap":12995482},{"date":"2025-01-24","current":-0.788664,"twenty":-24.633675,"median":-5.894009,"eighty":-2.052312,"marketCap":12791338},{"date":"2025-01-31","current":-0.791427,"twenty":-24.633675,"median":-5.894009,"eighty":-2.04294,"marketCap":12836150},{"date":"2025-02-07","current":-0.997726,"twenty":-24.623732,"median":-5.776129,"eighty":-2.038504,"marketCap":16182114},{"date":"2025-02-14","current":-1.099033,"twenty":-24.608818,"median":-5.658249,"eighty":-2.027617,"marketCap":17825220},{"date":"2025-02-21","current":-0.92282,"twenty":-24.608818,"median":-5.628779,"eighty":-2.021458,"marketCap":14967210},{"date":"2025-02-28","current":-0.775463,"twenty":-24.608818,"median":-5.099654,"eighty":-1.992156,"marketCap":12577236},{"date":"2025-03-07","current":-0.775156,"twenty":-24.608818,"median":-4.778496,"eighty":-1.977341,"marketCap":12572257},{"date":"2025-03-14","current":-0.75643,"twenty":-24.608818,"median":-4.719502,"eighty":-1.959028,"marketCap":12268531},{"date":"2025-03-21","current":-0.722967,"twenty":-24.608818,"median":-4.719502,"eighty":-1.953792,"marketCap":11725808},{"date":"2025-03-28","current":-0.540029,"twenty":-24.608818,"median":-4.704754,"eighty":-1.94913,"marketCap":9487224},{"date":"2025-04-03","current":-0.346542,"twenty":-24.608818,"median":-4.659207,"eighty":-1.929159,"marketCap":6088058}],"updateTime":1743755730711}}}